Indivior Pharmaceuticals (INDV)

• Market cap: $3.96B
• 1 day: 2.75%
• 5 days: 3.51%
• 1 month: 4.84%
• 3 months: -3.45%
• 6 months: 32.31%
• Year to date: -9.12%
• 1 year: 243.96%
• 5 years: 42.6%
• 10 years: 42.6%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).

Employees: 838